Sandrine Beauchard
Valence, 26400, France
Location status: Recruiting
NCT Number: NCT05618392
A 12 months mono-center, descriptive study, to evaluate pain and predictive factors Following placement of percutaneous Radiologic gastrostomy (PRG).
The primary objective is to evaluate the abdominal pain associated with percutaneous radiologic gastrostomy (PRG) placement.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Valence, 26400, France
Location status: Recruiting
PRG is a pathway first of all enteral nutrition that has several advantages: local anesthesia, possible in case of esophageal stenosis, Rates of successful tube placement higher for radiologic gastrostomy than for percutaneous endoscopic Gastrostomy (PEG).
Abdominal pain following percutaneous radiologic gastrostomy (PRG) placement is a recognized complication. However, the prevalence and degree of severity of pain are poorly characterized. This pain often requires antalgic treatment.
The primary objective is to evaluate the abdominal pain from Baseline until 7 days after radiologic gastrostomy (PRG) placement.
The secondary objective is to evaluate predictive factors
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 7 days
numerical scale 0 to 10, with 0 being "no pain" and 10 being "the worst pain imaginable."
Time frame: DAY 1
determine predictive factors of pain suspected in advance:
Contact information is provided by the study sponsor or research team.
Guillaume BUIRET, MD
CONTACT
Mathilde FINOT, MD
CONTACT
Centre Hospitalier de Valence
Other
Acronym: DOULEURGPR
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04804631
Bone Marrow Disease, Bone Marrow Diseases
London, United Kingdom
View Trial DetailsNCT07300865
Food Intolerance, Gastrostomy Complications
Uppsala, Sweden
View Trial DetailsNCT03920306
Gastrocutaneous Fistula, Gastrostomy Complications
Vancouver, British Columbia, Canada
View Trial DetailsNCT04001946
Gastrostomy Complications
Phoenix, Arizona, United States
View Trial Details